377 related articles for article (PubMed ID: 2566544)
1. Pharmacology of H2-receptor antagonists: an overview.
Schunack W
J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
[TBL] [Abstract][Full Text] [Related]
2. What are the differences between the H2-receptor antagonists?
Schunack W
Aliment Pharmacol Ther; 1987; 1 Suppl 1():493S-503S. PubMed ID: 2908767
[TBL] [Abstract][Full Text] [Related]
3. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
4. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
[TBL] [Abstract][Full Text] [Related]
5. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of the new H2-antagonists.
Walt RP
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of H2-receptor antagonists on drug interaction in rats.
Lin JH; Cocchetto DM; Yeh KC; Duggan DE
Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
[TBL] [Abstract][Full Text] [Related]
8. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
9. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
Langtry HD; Grant SM; Goa KL
Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of H2-receptor antagonists: current status of famotidine.
Levine JB
J Int Med Res; 1989; 17 Suppl 1():48A-53A. PubMed ID: 2566543
[TBL] [Abstract][Full Text] [Related]
11. Histamine H2-receptor antagonists.
Keithley JK
Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
[TBL] [Abstract][Full Text] [Related]
12. Clinical review of histamine2 receptor antagonists.
Lipsy RJ; Fennerty B; Fagan TC
Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
[TBL] [Abstract][Full Text] [Related]
13. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Campoli-Richards DM; Clissold SP
Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
[TBL] [Abstract][Full Text] [Related]
14. [The status of H2-blocker therapy today].
Rameis H
Wien Med Wochenschr; 1992; 142(18):398-405. PubMed ID: 1362029
[TBL] [Abstract][Full Text] [Related]
15. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
De Natale G; De Natale F; Marino A
Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of histamine H2-receptor antagonists.
Mills JG; Wood JR
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():87-95. PubMed ID: 2566729
[TBL] [Abstract][Full Text] [Related]
17. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
[TBL] [Abstract][Full Text] [Related]
18. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
19. Effect of famotidine on hepatic hemodynamics and peptic ulcer.
Ohnishi K; Saito M; Nomura F; Okuda K; Suzuki N; Ohtsuki T; Goto N; Takashi M
Am J Gastroenterol; 1987 May; 82(5):415-8. PubMed ID: 2883883
[TBL] [Abstract][Full Text] [Related]
20. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
Reeves JJ; Stables R
Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
